HIGHLIGHTS
- who: Jun Ho Ji et al. from the Division of Hematology and Oncology, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea have published the research work: Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma, in the Journal: (JOURNAL) of 22/03/2023
- what: In this review the authors aim to discuss the current state of immunotherapy for HCC the results of the biomarker studies and future direction. The authors aim to discuss predictive biomarkers for immunotherapy response in HCC, with a focus . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.